The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Freezing of Gait Program, 2025Treating Freezing of Gait in Parkinson’s Disease Using an ADHD Drug that Reduces Neural Cross-talk: A Multi-center Multi-modal Approach
Study Rationale: Freezing of gait affects four out of five people with Parkinson’s disease (PD), yet this debilitating symptom is not fully treated by any PD medication available. Research has shown...
-
Parkinson’s Disease Therapeutics Pipeline Program, 2024Investigation of a Novel Therapeutic Approach for Non-motor Symptoms of Parkinson’s Disease
Study Rationale:
Parkinson's disease (PD) is characterized by both motor symptoms and non-motor symptoms. While progress has been made in addressing motor symptoms, non-motor...
-
Research Grant, 2025The BioFINDER Studies: Identifying Disease Stages and Effects of Co-morbidities in Neuronal Synuclein Disease
Study Rationale: Neuronal synuclein disease (NSD) is the underlying cause of Parkinson’s disease (PD) and similar disorders. Recently, new tests have allowed us to measure signs of NSD before symptoms...
-
Spring 2022 RFA: Therapeutic Pipeline Program Pre-Clinical, 2024Exploring Paxalisib as a Novel Therapeutic for Parkinson’s Disease
Study Rationale: Studies in preclinical models of Parkinson’s disease (PD) and in postmortem PD brains suggest that a signaling pathway that is switched on by activation of a protein called...
-
ASAP CRN Competitive Renewal Opportunity, 2024Investigating How Alpha-synuclein-rich Neurons in Olfactory Circuits Respond to Environmental Triggers at the Initiation of Parkinson Disease
Study Rationale: To slow the progression of Parkinson disease (PD), we need to understand how, where and why the illness starts. It is estimated that most individuals with PD experience a significant...
-
Neuronal Synuclein Disease Endotypes 2024, 2025Using the Biopark Cohort to Study Neuronal Synuclein Disease Types
Study Rationale: To study the pathogenic processes underlying Parkinson’s disease (PD), we have recruited a cohort of several hundred people, including those with hereditary PD, those that carry PD...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.